Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines. (2023)
Attributed to:
Respiratory infections
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jinf.2023.03.027
PubMed Identifier: 37028454
Publication URI: http://europepmc.org/abstract/MED/37028454
Type: Journal Article/Review
Volume: 86
Parent Publication: The Journal of infection
Issue: 6
ISSN: 0163-4453